Effects of canagliflozin versus glimepiride on adipokines, inflammatory biomarkers, and chemokines in patients with type 2 diabetes mellitus
| Autor: | Garvey, W.T., Gaal, L.V., Leiter, L.A., Vijapurkar, U., List, J., Cuddihy, R., Ren, J., Davies, M.J., Fegade, M. |
|---|---|
| Zdroj: | In Indian Heart Journal November 2017 69 Supplement 2:S93-S94 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|